1. The additional value of lung cancer screening program in identifying unrecognized diseases
- Author
-
Panaiotis Finamore, Luigi Tanese, Filippo Longo, Domenico De Stefano, Claudio Pedone, Laura Angelici, Nera Agabiti, Silvia Cascini, Marina Davoli, Bruno Beomonte Zobel, Raffaele Antonelli Incalzi, and Pierfilippo Crucitti
- Subjects
Computed tomography ,Lung cancer ,Screening ,Cardiovascular disease ,Respiratory disorders ,Diseases of the respiratory system ,RC705-779 - Abstract
Abstract Background A systematic examination of low-dose CT (LDCT) scan, beside lung nodules, may disclose the presence of undiagnosed diseases, improving the efficacy and the cost/efficacy of these programs. The study was aimed at evaluating the association between LDCT scan findings and non-oncologic and oncologic diseases. Methods The LDCT scan of participants to the “Un Respiro per la vita”® lung cancer screening program were checked and abnormal findings, beside lung nodules, recorded. First admission to the acute care because of cardiovascular (CD), respiratory (RD) and oncological diseases (OD) in the following three years were retrieved. The association of LDCT scan abnormal findings with CD, RD and OD was assessed through univariable and multivariable logistic regression models. Results Mean age of 746 participants was 62 years (SD:5), 62% were male. 11 (1.5%) received a diagnosis of lung cancer. 16.1% participants were admitted to the acute care in the following three years: 8.6% for CD, 4.3% for RD and 5.2% for OD. Valve calcification (OR 2.02, p:0.02) and mucus plugs (OR 3.37, p:0.04) were positively associated with CD, while sub-pleural fibrosis had a protective role (OR 0.47, p:0.01). Lung nodules > 8 mm (OR 5.54, p:
- Published
- 2022
- Full Text
- View/download PDF